ZyCoV-D is a three-dose vaccine administered intradermally
02 Feb 2022 10:42 AM
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
07 Nov 2021 1:24 PM
The company's Covid vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20
31 Oct 2021 2:50 PM
The company has got the permission for conduct of phase III trials for two-dose Covid vaccine, Cadila Healthcare said in a regulatory filing
05 Oct 2021 5:22 PM
ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI)
30 Sep 2021 7:34 PM
The trials for the two-dose regimen are underway
12 Sep 2021 2:01 PM
The needle-free vaccine has shown an efficacy of 66.6 per cent in a late-stage trial of over 28,000 volunteers nationwide
23 Aug 2021 3:57 AM
Zydus Cadila announced that once they get clearance then they are expected to supply 5 crores doses per month till December 21
21 Aug 2021 5:45 PM
ZyCoV-D has become the first vaccine to be administered to those in the age group of 12-18 years in the country
20 Aug 2021 10:54 PM
Zydus Cadila has concluded its trial for children between the age group of 12 to 18
16 Jul 2021 1:37 PM
ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body
12 Jul 2021 1:01 PM
Covaxin is one of the only two indigenous COVID vaccine candidates approved for human clinical trials in India
27 Jul 2020 3:21 PM